Lancet:鼻中隔成形术治疗鼻中隔偏曲导致鼻阻塞

2019-07-26 MedSci MedSci原创

研究发现,对于鼻中隔偏曲导致鼻阻塞的成人,鼻中隔成形术可有效改善患者症状,且效果持久

鼻中隔成形术(鼻中隔偏曲外科矫正)是成人耳、鼻、喉手术中最常见的一种方法,近日研究人员评估鼻中隔成形术治疗鼻阻塞的效果。

成人(年龄≥18岁),鼻阻塞,鼻中隔偏曲,并有符合鼻中隔成形术指征患者,随机接受鼻中隔成形术,同时接受或不接受鼻甲手术或非手术治疗。患者按性别、年龄(<35岁或≥35岁)和偏差严重程度(轻度、中度或重度)进行分层。研究的主要结果是与健康相关的生活质量。

203名参与者接受鼻中隔成形术,同时接受或不接受鼻甲手术(n=102)或非手术治疗(n=101)。189名参与者在12个月时进行了分析。12个月时,接受隔膜成形术的格拉斯哥健康状况调查表(Glasgow)的平均分为72.2,接受非手术治疗的Glasgow健康状况调查表的平均分为63.9(平均差8.3,隔膜成形术组更佳)。其中1例手术患者出现中隔脓肿,2例手术患者出现中隔穿孔。没有鼻腔药物副作用的报告。

研究发现,对于鼻中隔偏曲导致鼻阻塞的成人,鼻中隔成形术可有效改善患者症状,且效果持久。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1966932, encodeId=088e1966932a5, content=<a href='/topic/show?id=830e1035383e' target=_blank style='color:#2F92EE;'>#鼻阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103538, encryptionId=830e1035383e, topicName=鼻阻塞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baf586, createdName=wangbingxhy, createdTime=Tue Nov 12 07:50:00 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004726, encodeId=09852004e260c, content=<a href='/topic/show?id=4e8a5400816' target=_blank style='color:#2F92EE;'>#成形术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54008, encryptionId=4e8a5400816, topicName=成形术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Thu Feb 27 03:50:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830174, encodeId=23b318301e4b0, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Nov 10 22:50:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992013, encodeId=51d71992013b0, content=<a href='/topic/show?id=1426103402c0' target=_blank style='color:#2F92EE;'>#鼻中隔偏曲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103402, encryptionId=1426103402c0, topicName=鼻中隔偏曲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Thu Apr 23 14:50:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696895, encodeId=a1cc1696895dd, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Wed Dec 18 11:50:00 CST 2019, time=2019-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604179, encodeId=389716041e94d, content=<a href='/topic/show?id=edfe103399a6' target=_blank style='color:#2F92EE;'>#鼻中隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103399, encryptionId=edfe103399a6, topicName=鼻中隔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Jul 28 09:50:00 CST 2019, time=2019-07-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1966932, encodeId=088e1966932a5, content=<a href='/topic/show?id=830e1035383e' target=_blank style='color:#2F92EE;'>#鼻阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103538, encryptionId=830e1035383e, topicName=鼻阻塞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baf586, createdName=wangbingxhy, createdTime=Tue Nov 12 07:50:00 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004726, encodeId=09852004e260c, content=<a href='/topic/show?id=4e8a5400816' target=_blank style='color:#2F92EE;'>#成形术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54008, encryptionId=4e8a5400816, topicName=成形术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Thu Feb 27 03:50:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830174, encodeId=23b318301e4b0, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Nov 10 22:50:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992013, encodeId=51d71992013b0, content=<a href='/topic/show?id=1426103402c0' target=_blank style='color:#2F92EE;'>#鼻中隔偏曲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103402, encryptionId=1426103402c0, topicName=鼻中隔偏曲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Thu Apr 23 14:50:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696895, encodeId=a1cc1696895dd, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Wed Dec 18 11:50:00 CST 2019, time=2019-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604179, encodeId=389716041e94d, content=<a href='/topic/show?id=edfe103399a6' target=_blank style='color:#2F92EE;'>#鼻中隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103399, encryptionId=edfe103399a6, topicName=鼻中隔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Jul 28 09:50:00 CST 2019, time=2019-07-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1966932, encodeId=088e1966932a5, content=<a href='/topic/show?id=830e1035383e' target=_blank style='color:#2F92EE;'>#鼻阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103538, encryptionId=830e1035383e, topicName=鼻阻塞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baf586, createdName=wangbingxhy, createdTime=Tue Nov 12 07:50:00 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004726, encodeId=09852004e260c, content=<a href='/topic/show?id=4e8a5400816' target=_blank style='color:#2F92EE;'>#成形术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54008, encryptionId=4e8a5400816, topicName=成形术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Thu Feb 27 03:50:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830174, encodeId=23b318301e4b0, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Nov 10 22:50:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992013, encodeId=51d71992013b0, content=<a href='/topic/show?id=1426103402c0' target=_blank style='color:#2F92EE;'>#鼻中隔偏曲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103402, encryptionId=1426103402c0, topicName=鼻中隔偏曲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Thu Apr 23 14:50:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696895, encodeId=a1cc1696895dd, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Wed Dec 18 11:50:00 CST 2019, time=2019-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604179, encodeId=389716041e94d, content=<a href='/topic/show?id=edfe103399a6' target=_blank style='color:#2F92EE;'>#鼻中隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103399, encryptionId=edfe103399a6, topicName=鼻中隔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Jul 28 09:50:00 CST 2019, time=2019-07-28, status=1, ipAttribution=)]
    2019-11-10 howi
  4. [GetPortalCommentsPageByObjectIdResponse(id=1966932, encodeId=088e1966932a5, content=<a href='/topic/show?id=830e1035383e' target=_blank style='color:#2F92EE;'>#鼻阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103538, encryptionId=830e1035383e, topicName=鼻阻塞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baf586, createdName=wangbingxhy, createdTime=Tue Nov 12 07:50:00 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004726, encodeId=09852004e260c, content=<a href='/topic/show?id=4e8a5400816' target=_blank style='color:#2F92EE;'>#成形术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54008, encryptionId=4e8a5400816, topicName=成形术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Thu Feb 27 03:50:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830174, encodeId=23b318301e4b0, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Nov 10 22:50:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992013, encodeId=51d71992013b0, content=<a href='/topic/show?id=1426103402c0' target=_blank style='color:#2F92EE;'>#鼻中隔偏曲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103402, encryptionId=1426103402c0, topicName=鼻中隔偏曲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Thu Apr 23 14:50:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696895, encodeId=a1cc1696895dd, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Wed Dec 18 11:50:00 CST 2019, time=2019-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604179, encodeId=389716041e94d, content=<a href='/topic/show?id=edfe103399a6' target=_blank style='color:#2F92EE;'>#鼻中隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103399, encryptionId=edfe103399a6, topicName=鼻中隔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Jul 28 09:50:00 CST 2019, time=2019-07-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1966932, encodeId=088e1966932a5, content=<a href='/topic/show?id=830e1035383e' target=_blank style='color:#2F92EE;'>#鼻阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103538, encryptionId=830e1035383e, topicName=鼻阻塞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baf586, createdName=wangbingxhy, createdTime=Tue Nov 12 07:50:00 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004726, encodeId=09852004e260c, content=<a href='/topic/show?id=4e8a5400816' target=_blank style='color:#2F92EE;'>#成形术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54008, encryptionId=4e8a5400816, topicName=成形术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Thu Feb 27 03:50:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830174, encodeId=23b318301e4b0, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Nov 10 22:50:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992013, encodeId=51d71992013b0, content=<a href='/topic/show?id=1426103402c0' target=_blank style='color:#2F92EE;'>#鼻中隔偏曲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103402, encryptionId=1426103402c0, topicName=鼻中隔偏曲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Thu Apr 23 14:50:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696895, encodeId=a1cc1696895dd, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Wed Dec 18 11:50:00 CST 2019, time=2019-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604179, encodeId=389716041e94d, content=<a href='/topic/show?id=edfe103399a6' target=_blank style='color:#2F92EE;'>#鼻中隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103399, encryptionId=edfe103399a6, topicName=鼻中隔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Jul 28 09:50:00 CST 2019, time=2019-07-28, status=1, ipAttribution=)]
    2019-12-18 tomyang96
  6. [GetPortalCommentsPageByObjectIdResponse(id=1966932, encodeId=088e1966932a5, content=<a href='/topic/show?id=830e1035383e' target=_blank style='color:#2F92EE;'>#鼻阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103538, encryptionId=830e1035383e, topicName=鼻阻塞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baf586, createdName=wangbingxhy, createdTime=Tue Nov 12 07:50:00 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004726, encodeId=09852004e260c, content=<a href='/topic/show?id=4e8a5400816' target=_blank style='color:#2F92EE;'>#成形术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54008, encryptionId=4e8a5400816, topicName=成形术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Thu Feb 27 03:50:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830174, encodeId=23b318301e4b0, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun Nov 10 22:50:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992013, encodeId=51d71992013b0, content=<a href='/topic/show?id=1426103402c0' target=_blank style='color:#2F92EE;'>#鼻中隔偏曲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103402, encryptionId=1426103402c0, topicName=鼻中隔偏曲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Thu Apr 23 14:50:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696895, encodeId=a1cc1696895dd, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Wed Dec 18 11:50:00 CST 2019, time=2019-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604179, encodeId=389716041e94d, content=<a href='/topic/show?id=edfe103399a6' target=_blank style='color:#2F92EE;'>#鼻中隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103399, encryptionId=edfe103399a6, topicName=鼻中隔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Jul 28 09:50:00 CST 2019, time=2019-07-28, status=1, ipAttribution=)]

相关资讯

Laryngoscope:下鼻甲外科手术的前瞻性、随机性和安慰剂对照研究

最近,有研究人员比较了射频治疗、二极管激光治疗、微吸割钻协助的下鼻甲形成技术在由下鼻甲肿大引起的慢性鼻阻塞中的治疗效果,并且将这些技术与安慰剂处理进行了比较。研究人员设计的研究为前瞻性的、随机的、单盲和安慰剂对照研究。研究包括了98名连续性的由于长期鼻炎引起的患有下鼻甲肿大的病人,并将他们以1:2:2:2的比例随机分配到安慰剂、射频治疗、二极管激光治疗、微吸割钻协助的下鼻甲形成技术治疗小组中。研究

Pediatr Allergy Immunol:鼻阻塞性疾病损害永久过敏性鼻炎青少年健康生活质量

之前,研究人员报道了在患有永久过敏性鼻炎(PER)的儿科病人鼻阻塞性疾病(NOD)较高的流行程度,并且PER对医学治疗并没有响应。最近,研究人员就NOD对该群体生活质量(QoL)的影响进行了研究。研究人员设计的现实生活预期研究包括了142名病人(6-11岁儿童41名,12-17岁青少年101名),这些病人患有中等或者严重的PER。在两个月的医学治疗后(鼻内类固醇和抗组胺),研究人员询问了他们的症状

Int Forum Allergy Rhinol:在过敏性鼻炎中,鼻通气功能是评估鼻一氧化氮诊断价值的重要因素

鼻一氧化氮(NO)在过敏性鼻炎(AR)诊断中的作用是具有争议的。最近,有研究人员在AR病人中,鉴定了能够影响鼻NO水平的因素,并且评估了鼻NO在AR诊断中的作用。研究包括了75名AR病人和31名健康对照。研究发现,鼻阻塞得分、嗜酸细胞阳离子蛋白(ECP)和鼻气道阻力(NAR)与鼻NO独立相关。鼻NO在鼻阻塞得分小于7(轻度到中度阻塞)的患者中的水平与对照相比,具有显著的增加(282.1 ± 122

Rhinology:过敏性鼻炎和非过敏性鼻炎病人鼻甲成形术后气流和症状结果分析

下鼻甲成形术被用来减轻医疗上难治性鼻阻塞。然而,阻塞的本质原因在过敏性鼻炎(AR)和非过敏性鼻炎(NAR)病人中是不同的。最近,有研究人员比较了术后AR病人和NAR病人治疗结果。研究人员设计的研究为案例-对照研究。参与的病人因鼻阻塞经历了鼻甲手术,其中包括具有鼻中隔成形术手术和不具有鼻中隔成形术手术。病人报道的结果有:鼻阻塞情况、全鼻功能(GNF)和鼻炎的鼻腔鼻窦结局测试(SNOT-22)、面部症

Head Neck Pathol:鼻中隔弯曲对鼻上皮的影响

鼻阻塞是当今ENT外科医生每天医疗实践中最常见的疾病之一。鼻中隔弯曲是鼻阻塞最为常见的原因。鼻中隔弯曲可以改变气道动态流动,这可以导致鼻粘膜各种各样的组织病理学变化。最近,有研究人员对组织病理学变化,比如淋巴细胞性浸润和鳞状上皮化生,在凹凸面进行了研究和比较。该预期随机性研究包括了42名鼻中隔弯曲的病人,这些病人是从 KLES Dr. Prabhakar Kore医院和医疗中心的耳鼻喉科住院部,并